Full List Of Stories
Small study shows convalescent plasma reduces risk of severe Covid-19
Convalescent plasma from patients who have already recovered from Covid-19 can help many older patients suffer a severe illness, a clinical study showed.
Friday preview: US December non-farm payrolls in the spotlight
All eyes will be on the monthly US non-farm payrolls report at the end of the week, which most economists - but not all - expect to show a further slowing in hiring as Covid-19 restrictions continue to bite.
Europe close: Shares continue to grind higher
European shares added to the prior session's gains on Thursday as investors were cheered by the prospect of a larger US stimulus package after the Democrats took control of Congress and Joe Biden's presidential election win was confirmed amid extraordinary scenes in Washington.
US services PMI beats forecasts in December, but strength overstated
Activity in US services beat forecasts by a large margin according to the results of a closely-followed survey.
BofA stays at 'buy' on BME European Value Retail, sees strong Q4
Analysts at Bank of America reiterated their 'buy' stance on shares of B&M European Value Retail arguing that the new lockdown in the UK should buoy the firm's sales.
Fed's Harker sees US GDP slowing 'significantly' in Q1
US gross domestic product growth will likely "slow significantly" in the first quarter of 2021 before picking up again later in the year, a top US central bank official said.
US foreign trade deficit widens in November on demand for cell phones
America's shortfall on trade with the rest of the world widened more than expected in November, in part amid stockpiling of cell phones and other household goods by firms ahead of the Christmas holidays.
US weekly jobless claim dip
Unemployment claims dipped in the US during the latest week for which data was available.
Covid-19 vaccine protection will likely last 'a couple' of years, Moderna boss says
Moderna boss Stephane Bancel said the protection against Covid-19 provided by the vaccine developed by his company is likely to last a couple of years.